These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 1336054

  • 1. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K, Perregaard J, Arnt J, Nielsen JB, Begtrup M.
    J Med Chem; 1992 Dec 25; 35(26):4823-31. PubMed ID: 1336054
    [Abstract] [Full Text] [Related]

  • 2. Selective, centrally acting serotonin 5-HT2 antagonists. 1. 2- and 6-substituted 1-phenyl-3-(4-piperidinyl)-1H-indoles.
    Perregaard J, Andersen K, Hyttel J, Sánchez C.
    J Med Chem; 1992 Dec 25; 35(26):4813-22. PubMed ID: 1336053
    [Abstract] [Full Text] [Related]

  • 3. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
    Andersen K, Liljefors T, Hyttel J, Perregaard J.
    J Med Chem; 1996 Sep 13; 39(19):3723-38. PubMed ID: 8809161
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles.
    Perregaard J, Moltzen EK, Meier E, Sánchez C.
    J Med Chem; 1995 May 26; 38(11):1998-2008. PubMed ID: 7783131
    [Abstract] [Full Text] [Related]

  • 6. Stereospecific and selective 5-HT2 antagonism in a series of 5-substituted trans-1-piperazino-3-phenylindans.
    Bøgesø KP, Arnt J, Hyttel J, Pedersen H.
    J Med Chem; 1993 Sep 17; 36(19):2761-70. PubMed ID: 8410990
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists.
    Balle T, Perregaard J, Ramirez MT, Larsen AK, Søby KK, Liljefors T, Andersen K.
    J Med Chem; 2003 Jan 16; 46(2):265-83. PubMed ID: 12519065
    [Abstract] [Full Text] [Related]

  • 8. Development of a receptor-interaction model for serotonin 5-HT2 receptor antagonists. Predicting selectivity with respect to dopamine D2 receptors.
    Andersen K, Liljefors T, Gundertofte K, Perregaard J, Bøgesø KP.
    J Med Chem; 1994 Apr 01; 37(7):950-62. PubMed ID: 8151622
    [Abstract] [Full Text] [Related]

  • 9. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M, Hallett DJ, Goodacre S, Moyes C, Crawforth J, Sparey TJ, Patel S, Marwood R, Patel S, Thomas S, Hitzel L, O'Connor D, Szeto N, Castro JL, Hutson PH, MacLeod AM.
    J Med Chem; 2001 May 10; 44(10):1603-14. PubMed ID: 11334570
    [Abstract] [Full Text] [Related]

  • 10. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
    Crawforth J, Goodacre S, Maxey R, Bourrain S, Patel S, Marwood R, O'Connor D, Herbert R, Hutson P, Rowley M.
    Bioorg Med Chem Lett; 2000 Dec 18; 10(24):2701-3. PubMed ID: 11133072
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
    Bøgesø KP, Arnt J, Frederiksen K, Hansen HO, Hyttel J, Pedersen H.
    J Med Chem; 1995 Oct 27; 38(22):4380-92. PubMed ID: 7473566
    [Abstract] [Full Text] [Related]

  • 13. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
    Vacher B, Bonnaud B, Funes P, Jubault N, Koek W, Assié MB, Cosi C, Kleven M.
    J Med Chem; 1999 May 06; 42(9):1648-60. PubMed ID: 10229633
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP, Martin GR, Mathews N, Milne A, Hobbs H, Dodsworth S, Sang PY, Knight C, Williams M, Maxwell M, Glen RC.
    J Med Chem; 1999 Jul 15; 42(14):2504-26. PubMed ID: 10411472
    [Abstract] [Full Text] [Related]

  • 16. Examination of the D2/5-HT2 affinity ratios of resolved 5,6,7,8,9,10-hexahydro-7,10-iminocyclohept[b]indoles: an enantioselective approach toward the design of potential atypical antipsychotics.
    Mewshaw RE, Abreu ME, Silverman LS, Mathew RM, Tiffany CW, Bailey MA, Karbon EW, Ferkany JW, Kaiser C.
    J Med Chem; 1993 Oct 15; 36(21):3073-6. PubMed ID: 7901415
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y, Harada H, Yoshikawa T, Yoshida N, Kato S.
    Chem Pharm Bull (Tokyo); 2002 Jul 15; 50(7):941-59. PubMed ID: 12130853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.